|
|
 |
|
Viewing report
|
|
|
|
The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma
Datamonitor, March 2008, Pages: 187
Today, pharma companies face growing competition from generics and me-too drugs, combined with increasingly tough P&R, a clamp down on healthcare spending, and the need to treat patients for longer due to the aging population. These factors threaten both current and future revenues prompting Pharma to adopt a range of corporate strategies to respond to the changing market dynamics.
Scope
- Review of key external factors impacting Pharma and shaping their strategies
- Analysis of steps undertaken by pharma companies to achieve cost saving and improve efficiency
- Assessment of corporate strategies employed by drug developers to generate new revenue growth
Highlights of this title
Fewer drugs are gaining FDA approval year-on-year, primarily due to increasing pressure the pharmaceutical industry is facing over drug safety, fueled by several recent high-profile drug withdrawals and black box warnings. Compounded with the recent expansion of the FDAs safety powers, this will have a negative impact on Pharmas profitability.
The pharmaceutical industry is facing increasingly cost-conscious times, with a declining ROI and numerous blockbuster products facing imminent generic competition. This is exacerbated by the increasing cost of licensing and M&A deals, and a harshening P&R environment.
A key trend in 2007 has been the vast number of job cuts across Big Pharma in an effort to cut costs, in response to disappointing financial results driven by patent expiries of key products and resulting generic erosion. Price pressure and low reimbursement rates, which are impacting company revenues, are set to continue in 2008.
Key reasons to purchase this title
- Identify the key trends that are impacting the industry in 2007, going forward in 2008 and beyond
- Understand what strategic steps pharma companies are making to maintain their profitability by cutting costs
- Gain insight into how Pharma are capturing new opportunities to sustain historic growth rates
Customers who bought this item also bought
Bio/Pharma R&D Statistical Sourcebook 2008/2009
The Indian Pharmaceutical Industry: Expansion & Ambitions + Indian Pharma Industry Tracker
Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry
New Approaches to Pharma R&D: Evolving Strategies to Rejuvenate R&D Efficiency
The Pharmaceutical Market Outlook to 2018: Key Threats and Opportunities for Big Pharma and its Responses to them
Generic Handbook: A Guide to the Generic Drug Industry in the US, 2007 Edition
The Pharma R&D Fact Book 2007
GenericHandbook - A Guide to the Generic Drug Industry in the US
The Rise of Mid-Sized Pharma
Biosimilars (2009 - 2014)
Pharma and the Feds: Key Government Activities and How They Affect the Biopharmaceutical Industry
Future Pharmaceutical Industry Trends: Long-term Opportunities Tempered by Short-term challenges
|
|
|
|
